Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| GLYC | GLYCOMIMETICS INC | United States | $19.66M | 64,450,385 | 35.53% | 64.47% | Net Buying | Net Buying |
| INTZ | INTRUSION INC | United States | $3.03M | 1,944,675 | 8.92% | 91.08% | Net Buying | Net Buying |
| ASLN | ASLAN PHARMACEUTICALS LTD | Singapore | $7.25M | 439,926,480 | 0.79% | 0.00% | ||
| PPBT | PURPLE BIOTECH LTD | Israel | $10.12M | 198,386,080 | 1.23% | 0.00% | ||
| IQ | IQIYI INC | China | $4.82B | 6,716,137,085 | 4.53% | 0.00% | ||
| GOEV | CANOO INC | United States | $166.15M | 64,397,326 | 44.63% | 55.37% | Net Buying | |
| CLNN | CLENE INC | United States | $50.22M | 128,430,098 | 9.06% | 52.69% | Net Buying | Net Selling |
| LIFE | ATYR PHARMA INC | United States | $117.32M | 69,010,940 | 59.74% | 22.13% | Net Buying | |
| CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $8.07M | 35,538,034 | 5.35% | 49.17% | Net Selling | Net Buying |
| APLM | APOLLOMICS INC | United States | $36.07M | 89,495,790 | 9.89% | 0.00% | ||
| BPTH | BIO-PATH HOLDINGS INC | United States | $2.04M | 678,795 | 3.24% | 96.76% | ||
| KZR | KEZAR LIFE SCIENCES INC | United States | $61.15M | 72,801,359 | 67.83% | 21.82% | Net Buying | |
| BIOL | BIOLASE INC | United States | $5.46M | 32,522,593 | 0.92% | 56.96% | ||
| APTO | APTOSE BIOSCIENCES INC | Canada | $19.33M | 15,717,701 | 7.58% | 67.78% | Net Buying | |
| GOSS | GOSSAMER BIO INC | United States | $165.59M | 226,218,652 | 86.47% | 13.53% | Net Buying | Net Selling |
| CKPT | CHECKPOINT THERAPEUTICS INC | United States | $60.31M | 35,686,279 | 13.69% | 8.02% | Net Selling | Net Selling |
| YTEN | YIELD10 BIOSCIENCE INC | United States | $3.10M | 641,738 | 2.09% | 97.91% | Net Buying | Net Buying |
| BNED | BARNES & NOBLE EDUCATION INC | United States | $12.54M | 53,156,369 | 22.27% | 77.73% | Net Selling | |
| LYRA | LYRA THERAPEUTICS INC | United States | $25.61M | 60,964,859 | 69.46% | 14.19% | Net Buying | |
| MVST | MICROVAST HOLDINGS INC | United States | $134.18M | 317,206,095 | 20.63% | 31.20% | Net Selling | |
| SONN | SONNET BIOTHERAPEUTICS HOLDINGS INC | United States | $5.49M | 3,069,516 | 1.86% | 98.14% | Net Buying | |
| OCUP | OCUPHIRE PHARMA INC | United States | $48.14M | 24,813,370 | 1.23% | 98.77% | Net Buying | Net Buying |
| AADI | AADI BIOSCIENCE INC | United States | $51.81M | 24,554,205 | 26.93% | 73.07% | Net Selling | Net Selling |
| VIRX | VIRACTA THERAPEUTICS INC | United States | $32.20M | 39,272,434 | 3.63% | 96.37% | Net Buying | Net Selling |
| TARA | PROTARA THERAPEUTICS INC | United States | $59.09M | 20,589,976 | 11.95% | 88.05% | Net Selling | |
| LUXH | LUXURBAN HOTELS INC | United States | $32.20M | 41,814,361 | 7.28% | 85.94% | Net Buying | |
| INAB | IN8BIO INC | United States | $43.72M | 43,287,325 | 19.83% | 52.04% | Net Buying | |
| MIST | MILESTONE PHARMACEUTICALS INC | Canada | $92.48M | 53,149,778 | 33.44% | 24.16% | ||
| IMRX | IMMUNEERING CORP | United States | $46.26M | 29,653,355 | 53.75% | 46.25% | Net Selling | Net Selling |
| GNLX | GENELUX CORP | United States | $98.06M | 26,865,473 | 21.54% | 5.21% | Net Selling | Net Selling |
| EVA | ENVIVA INC | United States | $39.63M | 74,496,537 | 27.69% | 72.31% | Net Selling | Net Selling |
| SYBX | SYNLOGIC INC | United States | $21.43M | 11,646,977 | 3.98% | 96.02% | Net Selling | Net Selling |
| FEMY | FEMASYS INC | United States | $31.38M | 22,099,347 | 6.42% | 8.05% | ||
| PRST | PRESTO AUTOMATION INC | United States | $13.57M | 80,791,967 | 8.56% | 68.69% | Net Buying | |
| GEVO | GEVO INC | United States | $173.87M | 236,232,717 | 35.74% | 11.14% | Net Selling | |
| VOR | VOR BIOPHARMA INC | United States | $119.98M | 68,168,771 | 87.43% | 10.17% | Net Selling | Net Selling |
| SGMT | SAGIMET BIOSCIENCES INC | United States | $138.19M | 31,913,887 | 39.98% | 60.02% | Net Buying | Net Buying |
| NTBL | NOTABLE LABS LTD | Israel | $9.65M | 9,018,261 | 2.63% | 97.37% | Net Selling | |
| CMMB | CHEMOMAB THERAPEUTICS LTD | Israel | $12.63M | 284,094,700 | 0.99% | 5.96% | ||
| CVKD | CADRENAL THERAPEUTICS INC | United States | $7.68M | 16,008,469 | 3.45% | 46.72% | Net Buying | |
| LUMO | LUMOS PHARMA INC | United States | $24.48M | 8,107,121 | 17.70% | 82.30% | Net Buying | Net Buying |
| PGEN | PRECIGEN INC | United States | $343.51M | 248,919,096 | 25.15% | 73.45% | Net Buying | Net Selling |
| EOSE | EOS ENERGY ENTERPRISES INC | United States | $133.95M | 202,645,716 | 46.82% | 14.34% | Net Selling | Net Buying |
| FBIO | FORTRESS BIOTECH INC | United States | $34.24M | 19,234,526 | 24.35% | 62.68% | Net Buying | Net Buying |
| TPST | TEMPEST THERAPEUTICS INC | United States | $80.34M | 22,192,026 | 4.15% | 95.85% | ||
| RBT | RUBICON TECHNOLOGIES INC | United States | $15.88M | 53,457,686 | 0.14% | 99.86% | Net Buying | Net Selling |
| MBRX | MOLECULIN BIOTECH INC | United States | $11.34M | 2,227,516 | 45.78% | 54.22% | Net Buying | |
| SPRB | SPRUCE BIOSCIENCES INC | United States | $32.88M | 41,149,160 | 63.59% | 36.41% | Net Selling | Net Selling |
| IKNA | IKENA ONCOLOGY INC | United States | $68.04M | 48,258,111 | 66.60% | 18.22% | ||
| MRNS | MARINUS PHARMACEUTICALS INC | United States | $85.79M | 54,642,580 | 81.93% | 18.07% | Net Buying | Net Buying |
| DDC | DDC ENTERPRISE LTD | China | N/A | 20,158,176 | 0.21% | 0.00% | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | United States | $78.17M | 27,918,560 | 18.78% | 38.25% | ||
| ACET | ADICET BIO INC | United States | $142.13M | 82,153,984 | 40.62% | 19.50% | Net Buying | |
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $106.84M | 13,012,876 | 13.26% | 86.74% | Net Buying | Net Buying |
| SGMO | SANGAMO THERAPEUTICS INC | United States | $96.61M | 178,906,350 | 48.59% | 17.99% | Net Selling | Net Selling |
| CMPS | COMPASS PATHWAYS PLC | United Kingdom | $548.50M | 64,227,371 | 35.78% | 53.45% | Net Selling | Net Selling |
| IVA | INVENTIVA SA | France | $179.80M | 52,115,807 | 9.33% | 0.00% | ||
| AQMS | AQUA METALS INC | United States | $54.86M | 111,953,875 | 17.59% | 15.42% | Net Selling | |
| VERV | VERVE THERAPEUTICS INC | United States | $515.09M | 83,619,279 | 62.25% | 37.75% | Net Buying | Net Selling |
| CLRB | CELLECTAR BIOSCIENCES INC | United States | $106.14M | 32,260,510 | 26.67% | 12.70% | ||
| HOOK | HOOKIPA PHARMA INC | United States | $81.83M | 98,950,107 | 35.22% | 26.83% | Net Buying | |
| PASG | PASSAGE BIO INC | United States | $87.85M | 55,598,796 | 43.60% | 56.40% | Net Buying | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.